in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance.
.
.
the report was compiled by outside researchers who went into the fda�s own database of �serious adverse [medical-drug] events.�
.
"we were fully aware of the fact that our twins would be the first babies in the world to receive this treatment in utero," corinna said.
.